全文获取类型
收费全文 | 977篇 |
免费 | 24篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 24篇 |
妇产科学 | 30篇 |
基础医学 | 85篇 |
口腔科学 | 9篇 |
临床医学 | 58篇 |
内科学 | 201篇 |
皮肤病学 | 62篇 |
神经病学 | 85篇 |
特种医学 | 29篇 |
外科学 | 220篇 |
综合类 | 2篇 |
预防医学 | 24篇 |
眼科学 | 8篇 |
药学 | 95篇 |
肿瘤学 | 64篇 |
出版年
2022年 | 10篇 |
2021年 | 11篇 |
2020年 | 5篇 |
2019年 | 15篇 |
2018年 | 5篇 |
2016年 | 7篇 |
2015年 | 15篇 |
2014年 | 20篇 |
2013年 | 17篇 |
2012年 | 39篇 |
2011年 | 31篇 |
2010年 | 5篇 |
2009年 | 15篇 |
2008年 | 27篇 |
2007年 | 33篇 |
2006年 | 43篇 |
2005年 | 26篇 |
2004年 | 36篇 |
2003年 | 27篇 |
2002年 | 25篇 |
2001年 | 30篇 |
2000年 | 30篇 |
1999年 | 28篇 |
1998年 | 15篇 |
1997年 | 10篇 |
1996年 | 15篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 15篇 |
1992年 | 48篇 |
1991年 | 37篇 |
1990年 | 47篇 |
1989年 | 31篇 |
1988年 | 47篇 |
1987年 | 30篇 |
1986年 | 24篇 |
1985年 | 19篇 |
1984年 | 21篇 |
1983年 | 20篇 |
1982年 | 8篇 |
1980年 | 8篇 |
1979年 | 12篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1974年 | 7篇 |
1972年 | 7篇 |
1971年 | 7篇 |
1970年 | 5篇 |
1969年 | 7篇 |
1968年 | 8篇 |
排序方式: 共有1005条查询结果,搜索用时 0 毫秒
81.
Y Aso 《Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology》1990,81(5):661-671
In adrenal surgery, of note are increase of the incidence of incidentaloma because of a rapid advance of various image diagnostic procedures, change of the approach of choice due to the more accurate preoperative localization of the adrenal lesions, and the treatment of bilateral lesions. Additionally, the treatments of adrenocortical carcinoma and malignant pheochromocytoma and the method of cortisol withdrawal in Cushing's syndrome were reviewed and discussed. It is important for urologists to perform adrenal surgery appropriately by preoperatively elucidating the full picture of adrenal disorder. 相似文献
82.
Y Homma T Ozawa E Higashihara Y Aso 《Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology》1991,82(5):792-798
Prostate thermotherapy consisting of 6 sessions of intrarectal 60 min irradiation of 915 MHz microwave generated by a prostathermer (Blodan, Isreal) was performed once or twice a week on 30 patients with benign prostatic hyperplasia. Excluding 2 cases who refused further therapy at the first session because of rectal discomfort, 28 cases were evaluated for the efficacy of the treatment. Good or fair improvement in subjective symptoms was observed in 24 (85.7%) of the cases. Nocturia was significantly relieved from 2.9 to 2.0 a night. Among the objective responses, no improvement was achieved as to residual urine or prostate size, while a significant increase of maximum or average flow rate on uroflowmetry was observed. Adverse effects were minor or moderate, including 2 cases of urethral bleeding and rectal discomfort, 2 cases of lower urinary tract infection and 1 case of hypotension, which occurred at the 5th session. The scoring criteria taking into account of both subjective and objective responses showed that the efficacy is good in 10 cases (33.3%) and fair or good in 20 cases (66.7%). These results indicated the usefulness of the prostathermer as one of non-surgical therapies for benign prostatic hyperplasia. 相似文献
83.
A Ishikawa M Sakaguchi M Nakano T Ushiyama N Ohta Y Ohtawara A Tajima K Kawabe Y Aso 《Hinyokika kiyo. Acta urologica Japonica》1991,37(10):1165-1168
To elucidate the relationship between cyclosporine (Cs) nephrotoxicity and renal blood flow (RBF), we carried our experiments using rats. Adult male Wistar strain rats each weighing about 100 g were used. Rats were divided into 2 groups; the Cs group (Cs 50 mg/kg/day was intraperitoneally given for 10 consecutive days) and the control group (normal saline solution for 10 consecutive days). The renal cortical blood flow was measured in each group by electrolytic hydrogen gas clearance method. We also carried out renal angiography with barium sulfate (BaSO4). Then we measured blood vessel area/renal sagittal section area ratio and the diameter of interlobar arteries. The Cs group showed a significant decrease of renal cortical blood flow compared with the control group. On the other hand there was no significant change in renal angiogram. In conclusion, Cs decreased renal cortical blood flow. We suppose that vascular resistance increased following afferent arteriolopathy caused by Cs administration. 相似文献
84.
A survey on incidental adrenal tumors in Japan. 总被引:24,自引:0,他引:24
A nationwide Japanese survey of 210 cases from 116 collaborating institutions demonstrated a dramatic increase in incidentally detected adrenal tumor from 4 cases in 1980 to 54 in 1988. The most common diagnosis was nonfunctioning cortical adenoma (69 cases), followed by pheochromocytoma (49). A total of 14 malignant tumors (6.7%) and 16 functioning benign cortical lesions was also found. Histological study revealed that functioning tumors were small and found in relatively young female patients, nonfunctioning cortical adenomas were of similar size but found in older patients, and all malignant tumors were larger than 6.5 cm. in diameter and occurred in patients 58 years or younger. These results indicate an increase in the occurrence of incidental adrenal tumor and the complexity of pathology. 相似文献
85.
Le Bihan D Joly O Aso T Uhrig L Poupon C Tani N Iwamuro H Urayama SI Jarraya B 《NeuroImage》2012,62(1):9-16
Diffusion-weighted MRI of non-human primates revealed that USPIO Bulk Magnetic Susceptibility (BMS) T2' effects of Ultrasmall Superparamagnetic Particles with Iron Oxide (USPIO) in the brain cannot be explained by a single compartment model, as diffusion and T2' effects appear coupled: Apparent Diffusion Coefficient (ADC) values depend on USPIO concentration and relaxivity effects of USPIO decrease with the b value. On the other hand, USPIO and diffusion effects could be well uncoupled using a model consisting in a fast and a slow diffusion pool with different relaxivities. Diffusion-weighting acts as a filter which emphasizes the contribution of the slow pool when increasing b values (apparent decrease in ADC and R2'). Those results have implications for human studies using BMS contrast agents, as well as BOLD and diffusion fMRI. 相似文献
86.
de la Calzada CS Sánchez Sánchez V Martín MT Tello De Meneses R Sánchez MA Jiménez JD Subías PE Gallego FG Aso JO Pita AM Salvador ML Rubia RG Simón PH;Sociedad Española de Cardiología 《Revista espa?ola de cardiología》2001,54(2):194-210
Primary pulmonary hypertension is a progressive disease. Most affected patients are young and middle-aged women. Etiology is unknown, although a familial and genetic factor is present in up to 6% of cases. Endothelial dysfunction and abnormalities in calcium channels of smooth muscle fibers are the present pathogenetics theories. Diagnostic tests try to exclude secondary causes of pulmonary hypertension and to evaluate its severity. Acute vasodilatory test is vital in the selection of treatment. Oral anticoagulation is indicated in all patients. Lung transplant is performed when medical treatment is unsuccessful. Atrial septostomy is an alternative and palliative treatment for selected cases. Chronic thromboembolic pulmonary hypertension is a special form of secondary pulmonary hypertension, clinically undistinguishable from primary primary hypertension, is of mandatory diagnosis because it can be cured with thromboembolectomy.Pulmonary embolism is common in hospitalised patients. The mortality rate for pulmonary embolism continues to be high: up to 30% in untreated patients. The accurate detection of pulmonary embolism remains difficult, as pulmonary embolism can accompany as well as mimic other cardiopulmonary illnesses. Non-invasive diagnostic tests have poor specificity and sensitivity. The D-dimer level and the spiral CT angiography have also been employed as new alternatives and important tools for precise diagnosis of suspected pulmonary embolism. The standard therapy of pulmonary embolism is intravenous heparin for 5 to 10 days in conjunction with oral anticoagulants posteriorly for 3 to 6 months. The incidence of deep venous thrombosis, pulmonary embolism and death due to pulmonary embolism, can be reduced significantly and shown clear benefits only by adoption of a prophylactic strategy with low-molecular-weight-heparins or dextrans in patients at risk. 相似文献
87.
Takebayashi K Matsumoto S Nakagawa Y Wakabayashi S Aso Y Inukai T 《The American journal of the medical sciences》2005,329(3):157-160
We describe a 56-year-old woman with type 2 diabetes complicated by a Klebsiella pneumoniae perirenal abscess. The patient further developed incipient diabetic ketoacidosis, disseminated intravascular coagulation, and endogenous endophthalmitis. Occurrence of the latter as a metastatic infection from perirenal abscess caused by this organism is very rare, and we know of no previously reported patient with the additional occurrence of disseminated intravascular coagulation. Since prompt intravitreal antibiotic administration is needed, physicians should be aware of these rare but severe complications of K pneumoniae infection, especially in patients with poorly controlled diabetes. 相似文献
88.
Sakamoto K Aso H Yokoyama T Kato K Nishiyama O Kimura T Kondoh Y Taniguchi H 《Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases》2007,81(4):403-407
We retrospectively reviewed 9 consecutive cases of primary pulmonary cryptococcosis having no comorbidity. At diagnosis, seven had no subjective symptoms and two had subtle symptom. Chest CT scan showed nodular shadows in 8, while 3 cases had infiltrative shadows. Eight of the nine were diagnosed with histopathology obtained by transbronchial lung biopsy or CT-guided needle aspiration biopsy. We also assessed PHA and Con A lymphocyte stimulation tests to measure cellular immune function in 6, four of whom showed decreased reaction of lymphocytes. We successfully treated seven of the nine with fluconazole alone and used fluconazole as a maintenance regimen in two. No relapse or treatment failure was seen after completion of antifungal treatment. Six cases were seropositive for serum cryptococcus antigen titer at diagnosis and only one showed seroconversion. We concluded that the duration of therapy for primary pulmonary cryptococcosis should not be necessarily determined by serum cryptococcus antigen seroconversion. 相似文献
89.
Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction. 总被引:1,自引:0,他引:1
Akira Tamura Maki Shingai Nobuko Aso Takayuki Hazuku Masaru Nasu 《Circulation journal》2003,67(9):742-744
The present study was designed to clarify whether osteopontin, an extracellular matrix protein, is released from the heart into the coronary circulation in patients with a previous (>3 months) anterior wall myocardial infarction (MI). Using a commercially available enzyme immunoassay kit, plasma concentrations of osteopontin were measured in 30 patients (26 men, 4 women; mean age, 61+/-12 years). Blood samples were obtained from the aortic root and coronary sinus. The difference in the plasma concentrations of osteopontin in the aortic root and coronary sinus, which reflects the cardiac production of osteopontin released into the coronary circulation, was compared with the left ventricular ejection fraction (LVEF) and volumes obtained from contrast left ventriculography. Plasma osteopontin concentrations were significantly higher in the coronary sinus than in the aortic root (672+/-446 vs 610+/-398 ng/ml, p=0.02). The transcardiac gradient of plasma osteopontin concentration correlated negatively with LVEF (r=-0.55, p=0.0005) and positively with left ventricular (LV) end-diastolic (r=0.63, p=0.0001) and end-systolic volume indexes (r=0.79, p<0.0001). This is the first study to show that in patients with a previous anterior wall MI osteopontin is released from the heart into the coronary circulation in proportion to the LV systolic function and volumes, suggesting that this extramatrix protein is associated with post-MI LV remodeling. 相似文献
90.
Inhibitory effect of angiotensin Ⅱ receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis 总被引:6,自引:0,他引:6
Yokohama S Tokusashi Y Nakamura K Tamaki Y Okamoto S Okada M Aso K Hasegawa T Aoshima M Miyokawa N Haneda M Yoneda M 《World journal of gastroenterology : WJG》2006,12(2):322-326
AIM: To investigate the efficacy of angiotensin II receptor antagonist on hepatic stellate cells (HSCs) activation in the patients with non-alcoholic steatohepatitis (NASH). METHODS: Seven patients with NASH were prescribed losartan, a selective angiotensin II type 1 receptor antagonist (50 mg/d) for 48 wk. Liver biopsies were performed both at the entry and end of the study in all patients. Quiescent and activated HSCs were identified by double immunostaining using anti-p75 and -smooth muscle actin antibodies, and the number of each phenotype was counted. Similarly, the liver specimens obtained from the eight patients with non-alcoholic fatty liver (NAFL) were also examined as controls. RESULTS: In NASH hepatic tissues, activated HSCs were dominantly distributed as compared with those in NAFL. The 48-wk losartan treatment induced a remarkable decrease in activated HSCs and a mild increase in quiescent phenotypes. CONCLUSION: Our data suggest the crucial involvement of HSCs in anti-fibrotic effect of angiotensin II receptor antagonist on patients with NASH. 相似文献